• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804400-38
Medical Device Problem Codes Difficult to Remove (1528); Material Separation (1562); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/23/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that while an unspecified guide wire was in the anatomy, the 4.0x38 mm xience skypoint stent delivery system (sds) was attempted to be advanced over the guide wire but it became stuck as the guide wire wasn't wiped prior to advancement.During advancement, the nose cone separated.The device and nose cone were subsequently removed from the wire and the wire remained in place.There was also resistance when removing the xience skypoint sds from the guide wire.The sds never made it into the anatomy.There were no adverse patient effects and there was no reported clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
The device was returned for analysis.The reported tip separation was confirmed.The reported failure to advance and difficulty to remove could not be replicated in a testing environment as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16714499
Report Number2024168-2023-03686
Device Sequence Number1614942
Product Code NIQ
UDI-Device Identifier08717648233524
UDI-Public08717648233524
Combination Product (Y/N)Y
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/28/2025
Device Model Number1804400-38
Device Catalogue Number1804400-38
Device Lot Number3010341
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/07/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/23/2023
Supplement Date Received by Manufacturer05/03/2023
Initial Report FDA Received Date04/11/2023
Supplement Report FDA Received Date05/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/29/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
UNSPECIFIED GUIDE WIRE.
Patient Age46 YR
Patient SexMale
-
-